SYNTHEKINE
Synthekine is an engineered cytokine therapeutics company that creates selective immunotherapies to improve cancer and inflammatory disease treatment paradigms. Using knowledge of cytokine structure and function, the company develops therapeutics that maximize cytokine efficacy while avoiding toxic side effects. Synthekine is developing a broad and deep pipeline of product candidates by leveraging principles of cytokine partial agonism and immunological specificity across multiple protein engineering platforms. Modified cytokines, cytokine-enhanced cell therapies, and surrogate cytokine agonists are among the novel immunotherapies.
SYNTHEKINE
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2018-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.synthekine.com
Total Employee:
51+
Status:
Active
Contact:
(650) 271-9888
Total Funding:
289.5 M USD
Technology used in webpage:
CrUX Dataset CrUX Top 10m Lorem Ipsum MediaElement.js Comcast
Similar Organizations
Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
Amunix
Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.
Black Diamond Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Synlico
Synlico develops a CAR-T cell therapy by combining system biology, single-cell bioinformatics, and synthetic biology.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Board_member
2019-03-01
Board_member
2020-09-01
Board_member
2020-09-01
Board_member
2021-05-01
Board_member
2020-09-01
Current Employees Featured
Debanjan Ray Chief Executive Officer @ Synthekine
Chief Executive Officer
2019-05-01
K. Christopher Garcia Founder @ Synthekine
Founder
Geoff Nosrati Chief Business Officer @ Synthekine
Chief Business Officer
2023-10-01
Martin Oft Chief Development Officer @ Synthekine
Chief Development Officer
2019-02-01
Founder
Investors List
The Column Group
The Column Group investment in Series C - Synthekine
RA Capital Management
RA Capital Management investment in Series B - Synthekine
Rock Springs Capital
Rock Springs Capital investment in Series B - Synthekine
Deerfield
Deerfield investment in Series B - Synthekine
The Column Group
The Column Group investment in Series B - Synthekine
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Synthekine
Omega Funds
Omega Funds investment in Series B - Synthekine
Canaan Partners
Canaan Partners investment in Series B - Synthekine
Samsara BioCapital
Samsara BioCapital investment in Series B - Synthekine
TCG Crossover
TCG Crossover investment in Series B - Synthekine
Key Employee Changes
| Date | New article |
|---|---|
| 2024-02-21 | Synthekine Appoints Geoff Nosrati, Ph.D., as Chief Business Officer and Announces Executive Leadership Changes |
Official Site Inspections
http://www.synthekine.com Semrush global rank: 7.81 M Semrush visits lastest month: 772
Unable to get host informations!!!
More informations about "Synthekine"
About Us | Synthekine
Nov 15, 2021 Prior to Synthekine, Martin co-founded ARMO Biosciences, where he oversaw …See details»
Synthekine | Cytokines by Design
Discovering, Developing and Commercializing the Next Generation of Selective Cytokine Therapeutics. We believe that cytokine therapeutics engineered to …See details»
Synthekine - Crunchbase Company Profile & Funding
Synthekine is an engineered cytokine therapeutics company that creates selective immunotherapies to improve cancer and inflammatory disease …See details»
about - Synthekine
Jan 10, 2022 Synthekine is a biotechnology company focused on developing innovative therapies for patients with unmet medical needs.See details»
Synthekine Company Profile 2024: Valuation, Funding …
Synthekine General Information Description. Developer of engineered cytokine therapeutics designed to facilitate disease-optimized treatments. The …See details»
Synthekine - LinkedIn
Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate ...See details»
Synthekine - Contacts, Employees, Board Members, Advisors
Organization. Synthekine . Connect to CRM . Save . Summary. Financials. People. …See details»
Synthekine Company Profile - Craft
Synthekine is a biotechnology company that specializes in the discovery and development of …See details»
Synthekine - Funding, Financials, Valuation & Investors - Crunchbase
Synthekine is a development stage biotherapeutics company focused on the engineering of …See details»
Synthekine - Overview, News & Similar companies | ZoomInfo.com
Mar 26, 2024 Synthekine Announces Presentation of Initial Results from Phase 1a/1b Clinical …See details»
Mission, Vision & Core Values of Synthekine – CBM
Synthekine is a cutting-edge biotechnology company on a mission to revolutionize the field of …See details»
Synthekine Strengthens Leadership with Board of Directors …
“Synthekine is built on remarkable cytokine research and I have been truly impressed with how …See details»
Synthekine debuts with $82M, Stanford tech to create a new …
Sep 17, 2020 Synthekine is developing STK-009 for use with SYNCAR-001, a CD-19 …See details»
Synthekine Establishes Collaboration with Merck to Develop …
Nov 1, 2021 Synthekine will be eligible for up to $525 million in development, regulatory and …See details»
One of a 'Kine': Synthekine Engineers Cytokine Therapeutics to …
May 26, 2022 The leaders in this organization have spent decades working on cytokines. …See details»
Our Platforms | Synthekine
To accomplish that, we have developed three distinct cytokine engineering platforms at …See details»
Merck teams up with Synthekine in $525m cytokine partnership
4 days ago Merck & Co has made another move towards diversifying its pipeline and …See details»
Synthekine: beyond cytokines - Nature
Jun 9, 2021 Synthekine is advancing a human version. Synthekine’s IL-2 receptor, expressed …See details»
Our Pipeline | Synthekine
Synthekine Inc. (“Synthekine”) is committed to developing safe and effective medicines …See details»
Synthekine Establishes Collaboration with Merck to Develop …
Synthekine is harnessing the potential of cytokine therapeutics to develop selective …See details»